Kroger (KR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 26, 2025, with voting on 10 director nominees, executive compensation, auditor ratification, and three shareholder proposals.
Strategic focus on Fresh, Our Brands, personalization, and eCommerce, with significant investments in new stores and digital business units in 2024.
Commitment to supporting associates through wage and benefit improvements, and to strengthening communities via the Zero Hunger | Zero Waste initiative.
Forward-looking statements highlight ongoing capital deployment, operational goals, and risk factors.
Voting matters and shareholder proposals
Shareholders will vote on: election of directors, advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as auditor, and three shareholder proposals (discarded cigarette pollution, third-party framework on U.S. farmers, and consumer health data privacy).
Board recommends voting FOR all director nominees, FOR executive compensation and auditor ratification, and AGAINST all shareholder proposals.
Shareholder proposals address environmental, social, and privacy issues; Board responses emphasize existing programs and resource allocation.
Board of directors and corporate governance
Board consists of 10 members, with a mix of tenure and diversity; 5 women and 4 racially/ethnically diverse directors.
All director nominees except the CEO are independent; all five Board committees are fully independent.
Lead Director role held by Mark S. Sutton, providing oversight and succession planning.
Annual Board and Committee self-assessments, robust code of ethics, and regular executive sessions.
Proxy access allows shareholders (3% ownership for 3 years) to nominate directors.
Latest events from Kroger
- Strong sales, margin gains, and eCommerce growth, with 2026 guidance signaling continued momentum.KR
Q4 20265 Mar 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q1 sales and digital growth offset profit declines as guidance and merger focus remain.KR
Q1 20253 Feb 2026 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 202520 Jan 2026 - Q3 digital and pharmacy gains offset lower fuel sales; Albertsons merger terminated, $7.5B buyback set.KR
Q3 202511 Jan 2026 - Strong 2024 sales and digital growth set the stage for further gains and capital returns in 2025.KR
Q4 20256 Jan 2026 - Q2 2025 delivered strong sales, margin growth, and raised guidance, led by eCommerce and pharmacy.KR
Q2 202615 Dec 2025 - Adjusted EPS rose 7% to $1.05, but a $2.6B impairment drove a net loss.KR
Q3 202612 Dec 2025 - Virtual meeting to vote on directors, pay, auditor, and key proposals; board supports all nominees.KR
Proxy Filing1 Dec 2025